baber/WOPTO huggingface dataset:
Patent NZ-506123-A (NZ)
Title: Dual-polarized dipole antenna
Inventor: GABRIEL ROLAND
IPC: H01Q21/26
Filed: 1999-12-16
Abstract: A dual-polarized dipole radiator comprises a plurality of individual dipoles which are preferably arranged upstream of a reflector (33) and form a dipole square structurally in top view, each dipole (111-114) being fed by means of a symmetrical line (115-118). The dual-polarized dipole radiator radiates electrically in a polarization at an angle of +45.degree or -45 degree. To the structurally prescribed alignment of the dipoles (111-114) the end of the symmetrical or substantially or approximately symmetrical lines leading to the respective dipole halves (111a to 114b) are connected up in such a way that the corresponding line halves (115a to 118b) of the adjacent, mutually perpendicular dipole halves (114b and 111a; 111b and 112a; 112b and 113a; 113b and 114a) are always electrically connected. The electric feeding of the respectively diametrically opposite dipole halves is performed in a decoupled fashion for a first polarization and a second orthogonal polarization.
Patent NZ-506270-A (NZ)
Title: Combination drilling and wrenching tool with sleeve able to be located over drill with bit, and reversible end to end, typically to allow different size fasteners to be wrenched
Inventor: VAUGHAN JAMES C
IPC: B25B21/00
Filed: 2000-08-10
Abstract: Drilling and wrenching tool 10 for use with rotary power tool 20 and combinations thereof are disclosed. Tool 10 includes drill adapter 100 having drill bit 40 protruding from a drill shank 120 thereof, and a sleeve member 200 having a first end with a first opening 201 and a second opposite end with a second opening 203. The first opening of the sleeve member has a first sleeve engagement surface 206 and a first fastener engagement surface 208, and the second opening has a second sleeve engagement surface 207 and a second fastener engagement surface 209. The drill shank is axially disposable into the first or second opening of the sleeve member, and an outer shank engagement surface of the drill shank is engagable with the first or second sleeve engagement surface to impart rotation from the rotary power tool to the sleeve member.
Patent NZ-509813-A (NZ)
Title: Process to collect metabolites from modified nectar by insects
Inventor: CREEMERS JANTINA
IPC: C07K14/415
Filed: 1999-07-15
Abstract: An isolated DNA sequence having promoter activity from the promoter region upstream of a nectary-specific expressed sequence, the nectary-specific expressed sequence encoding a protein having amino acid sequence SEQ ID NO.1. The isolated DNA sequence can be used to produce plants capable of excretion of a recombinant protein in its nectar.
Patent NZ-510790-A (NZ)
Title: Food bar containing cooked cereal bases
Inventor: DESJARDINS JEAN-JACQUES
IPC: A23L7/17
Filed: 2001-03-27
Abstract: A ready to eat food bar consists of agglomerated particles of one or more cooked cereal bases mainly comprising amylaceous materials and possibly milk solids. The cereal bases are coated with a binder mainly comprising sugars, milk solids, humectants and fat. The food bar is manufactured by a process comprising preparing a dry mixture of particles of one or more cooked cereal bases mainly comprising amylaceous materials and possibly milk solids. The dry mixture is mixed with the binder mainly comprising sugars, milk solids, humectants and fat. The mixture obtained is then formed into a bar shape. The particles of cooked cereal may include rolled cereals, gun puffed grains, cereal flakes and/or cooked-extruded cereals
Patent NZ-510896-A (NZ)
Title: Cavitated pad and innerspring assembly combination having springs with free terminal convolutions
Inventor: BARMAN BRUCE G
IPC: A47C27/06
Filed: 1999-07-09
Abstract: A cavitated pad and innerspring assembly combination, for use in mattresses, furniture, or other cushioned flexible support structures, wherein coils of the innerspring assembly have terminal convolutions which extend beyond the coil body and are not connected to adjacent coils. A cavitated pad has openings in which the terminal convolutions fit, and the pad overlies the coil bodies. In one embodiment, the cavitations extend either partially or entirely through the pad. Upholstery is attached over the pad. The combination of coils with terminal convolutions positioned within the cavitations in the pad provides a dampened or attenuated dual spring rate support surface with controlled lateral deflection of the terminal convolutions.
Patent NZ-511646-A (NZ)
Title: Two chamber cartridge for nebulisers where the chamber is tightly sealed by a moveable plunger and a guide tube leading to the plunger
Inventor: ZIERENBERG BERND
IPC: A61B19/00
Filed: 1999-10-09
Abstract: The device consists of a closing cap and a container in the form of a two chamber cartridge in which an active substance and a solvent can be stored separately until the device is used in an atomizer and to an active substance concentrate in which the active substance used for storing is present as a solution or suspension.
Patent NZ-513137-A (NZ)
Title: Two part anchoring adhesive putty with the two parts being in a side by side relationship
Inventor: HACKL CYNDIE S
IPC: C08G59/50
Filed: 2001-07-26
Abstract: An anchoring adhesive, comprising: a first part comprising a resin such as an epoxy resin, and having a viscosity of about 5 million to 50 million centipoise; and a second part comprising a curing agent such as a tertiary amine compound, and having a viscosity of about 5 million to 50 million centipoise; optionally the first part may further comprise a particulate filler; the first and the second parts being directly joined along an interface.
Patent NZ-516250-A (NZ)
Title: Recombinant anti-CD40 antibody and uses thereof
Inventor: SIEGALL CLAY B
IPC: A61P21/00
Filed: 2000-06-08
Abstract: A protein comprises SEQ ID NO:3, 4, 8, 9 or 10, binds immunospecifcally to CD40 and comprises one or more substitution or insertions in its primary amino acid sequence relative to native monoclonal antibody S2C6 as secreted by the hybridoma ATCC PTA-110. The protein competes for binding to CD40 with the monoclonal antibody S2C6 and increases the binding of CD40 ligand to CD40. Also described are nucleic acids, recombinant cells, methods of producing the protein and pharmaceutical compositions comprising the proteins and nucleic acids. The pharmaceutical compositions are useful for activating or augmenting the immune response, and for the treatment cancer or an immune disorder.
Patent NZ-517013-A (NZ)
Title: Process for preparing amlodipine benzenesulphonate from phthalamidic acid derivatives
Inventor: FISCHER JANOS
IPC: C07D211/80
Filed: 1999-07-05
Abstract: Amlodipine benzenesulphonate of formula (I) can be prepared by reacting phthalamidic acid derivative of formula (II) with benezenesulphonic acid wherein X is hydrogen, alkali metal, alkali earth metal or quaternary ammonium. Also described is the compound of formula (II) and the process to prepare the compound.
Patent NZ-523188-A (NZ)
Title: Use of a betablocker in the manufacture of a medicament to treat artherosclerosis
Inventor: BERGLUND GORAN
IPC: A61P25/28
Filed: 2001-06-15
Abstract: Pharmaceutical formulations comprising a betablocker, in a maintenance dose lower than 50 mg, particularly in the range of 25 to 47 mg, optionally containing a cholesterol lowering agent, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier. A method of treatment and use of the formulations for the treatment of atherosclerosis and related diseases is also disclosed.
Patent NZ-526194-A (NZ)
Title: Methods of covalently linking, in one or both strands, two or more double stranded nucleotide sequences using one or more topoisomerases
Inventor: CARRINO JOHN
IPC: C12N9/90
Filed: 2001-12-07
Abstract: Aromatic di-keto derivatives and their pharmaceutically acceptable salts, esters, ethers and other obvious chemical equivalents are described. The derivatives are glucose-6-phosphate translocase inhibitors and can be used in the treatment of diabetes mellitus. Further described is a process for the production of the derivatives, to the use of the derivatives and their pharmaceutically acceptable salts, esters, ethers and other obvious chemical equivalents as pharmaceuticals, in particular to their use in the treatment of diabetes mellitus, and to pharmaceutical compositions comprising the derivatives etc.
Patent NZ-527010-A (NZ)
Title: High strength lever handle lock mechanism
Inventor: ELLER DARREN C
IPC: E05B63/10
Filed: 2002-01-16
Abstract: A lock mechanism for use with lever handles 36, 74 that is strong and resistant to abuse is described. The mechanism includes a latch mechanism 18 that is rigidly connected to a lock core 10. Stops and a spring return mechanism are entirely located within the lock core 10, allowing the rose 50 to be thin. The lock core 10 defines the rest position for the lever handles at an angle slightly above horizontal. The lock core 10 is substantially symmetrical about a vertical plane, instead of a horizontal plane, and the inner and outer sides of the lock mechanism can be interchanged. A heavy-duty locking piece, including a pair of locking lugs that directly engage the lock core near its inner perimeter, allow the lock to withstand abusive forces applied through the lever handle. Endplay is nearly completely eliminated through the use of collars 48, 70 that connect the interchangeable inner and outer sides of the lock to the lock core 10.
Patent NZ-534988-A (NZ)
Title: Method and system for the automatic planning of experiments
Inventor: BURGHAUS ROLF
IPC: G06F17/50
Filed: 2003-02-17
Abstract: A method for the automatic design of experiments is disclosed which includes the steps of (a) inputting d-dimensional parameter space, (b) inputting the number M of experiments to be designed, (c) inputting a similarity measure of two experiments, (d) inputting a weighting measure for an individual experiment, (e) determining a quality measure for a selected set of M experiments based on the summed similarity measures and the summed weighting measures of all of the experiments, (f) finding a set of number M of experiments in which the quality measure assumes an extreme value, which is the experiments which are as dissimilar as possible, and which show a uniform distribution in the parameter space. Finally, step (g) output M experiments.
Patent NZ-536241-A (NZ)
Title: Method of and equipment for checking support means
Inventor: LUSTENBERGER MARTIN
IPC: G01N25/72
Filed: 2004-10-29
Abstract: A method and equipment for checking a support device such as those used in an elevator installation. The method and equipment detects reductions in cross-section of the tensile supports in the support device by heating the tensile supports with electrical current flow and determining the temperature at surface of surrounding sheathing. An increase in the temperature from an original measurement is an indicator of damage to the tensile supports.
Patent NZ-544164-A (NZ)
Title: Anti-viral and anti-bacterial cleaning composition
Inventor: MALYSZEWICZ CHRISTOPHER
IPC: C11D3/30
Filed: 2004-05-17
Abstract: Disclosed is a cleaning and disinfecting composition comprising at least one alcohol, at least one long-chain alkyl polyamine, and at least one halogen, wherein the long-chain alkyl polyamine compound comprises a compound of the general formula H2N(CH2)3-NR-(CH2)3NH2, where R is a linear or branched alkyl chain comprising at least eight carbon atoms.
Patent NZ-544685-A (NZ)
Title: Pharmaceutical formulations of amyloid inhibiting compounds
Inventor: LEGORE AUDLEY
IPC: A61K31/185
Filed: 2004-06-21
Abstract: Disclosed is a formulation comprising 3-amino-1-propanesulfonic acid, or a salt thereof, and an enteric coating, for oral treatment or prevention of an amyloid-related disease such as Alzheimer's disease, cerebral amyloid angiopathy, inclusion body myositis, macular degeneration, Down's syndrome, mild cognitive impairment, cognitive decline or hereditary cerebral hemorrhage.
Patent NZ-554279-A (NZ)
Title: Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
Inventor: RONDOT BENOIT
IPC: A61K31/416
Filed: 2005-10-14
Abstract: Disclosed are indazoles, benzisoxazoles and benzisothiazoles compounds of formula (I) or acid addition salts or a stereoisomeric forms thereof and their use for treating cognitive dystunction and estrogen dependent disorders.
Patent NZ-563876-A (NZ)
Title: Emergency lighting system
Inventor: HO DANG HAI
IPC: H04W84/18
Filed: 2007-07-19
Abstract: An emergency system for providing an emergency function comprises a plurality of wireless emergency devices with each device for providing the emergency function; a controller for dividing the plurality of wireless emergency devices into a plurality of different groups of wireless emergency devices such that wireless emergency devices in close proximity are in different groups and a transmitter controlled by the controller for transmitting a signal to a group of wireless emergency devices to initiate a test operation and so wireless emergency devices in the group are able to communicate data back to a control receiver relating to the test operation. The controller controls initiation of the test operation of groups of wireless emergency devices so that at least one group of the wireless emergency devices can provide the emergency function during testing.
Patent NZ-566071-A (NZ)
Title: Business form and self-laminating wristband with improved print area and single layer straps
Inventor: RILEY JAMES M
IPC: G06F3/00
Filed: 2006-06-27
Abstract: A business form including a wristband is provided with a print area forming a badge, the badge having a length less than and a width greater than a width of either of two straps used to attach the wristband to the wrist, the badge thus having a greater print area to improve the readability of the indicia displayed therein. A business form including a wristband has a bulged rectangularly shaped print area to allow information to be printed transversely across the print area to improve readability of the indicia displayed in the print area. Thus, the bulged rectangularly shaped print area can accommodate one or both of bar codes printed thereon in ladder as well as picket fence fashion.; A security seal is disclosed which comprises a small, adhesive coated patch of laminate for sealing the joinder of the wristband ends and which has points of weakness such as X's die cut therein so that it separates or destructs upon removal to provide an indication of tampering with the wristband. Also disclosed is an embodiment of the wristband form that is imprinted with identifying indicia for collecting, tracking and administering a patient's blood collection and blood product compatibility.
Patent NZ-567424-A (NZ)
Title: Fall arrest/industrial rope access safety testing and tracking system where a tag containing load rating information is applied to each roof anchor tested
Inventor: MCIVER LINDSAY
IPC: G09F3/08
Filed: 2008-04-14
Abstract: A method of safety for a fall arrest system is disclosed. The method includes the steps of: (a) determining an initial rating of a fall arrest roof anchor and/or other components of the fall arrest system to indicate characteristics including maximum weight load; (b) providing a coding system to indicate the determined initial rating of the roof anchors; and (c) marking the roof anchor with at least one tag with the determined indicated initial rating according to the coding system. The user of the fall arrest roof anchors and/or other components of the fall arrest system can thereby readily determine the capability of the system.
Patent NZ-569140-A (NZ)
Title: Dioxolane derivatives for the treatment of cancer
Inventor: MYHREN FINN
IPC: A61K31/52
Filed: 2006-12-07
Abstract: The disclosure relates to certain unsaturated fatty acid derivatives of therapeutically active 1,3-dioxolane nucleoside analogues and to pharmaceutical formulations containing them. The said derivatives compounds are represented by formula (I). Compounds of formula (I) can be used in the treatment of a cancerous disease. Treatment of both solid tumours and haematological cancers such as leukaemias, lymphomas and multiple myelomas are included.
Patent NZ-573611-A (NZ)
Title: Uv absorbing polymeric composition with titanium dioxide particles
Inventor: TOOLEY IAN ROBERT
IPC: C09C1/36
Filed: 2007-06-07
Abstract: Disclosed is a UV absorbing polymeric composition having an extinction coefficient at 524nm (E524) of less than 2.0 l/g/cm, an extinction coefficient at 308 nm (E308) of greater than 20 l/g/cm and an E308/E524 ratio of greater than 10 which comprises an organic resin, titanium dioxide particles and an organic dispersing medium, is obtained by (i) forming a masterbatch composition by mixing a dispersion of titanium dioxide particles having a median particle volume diameter of less than 85nm in an organic dispersing medium with an organic resin, and mixing the masterbatch composition with a suitable organic resin, or (ii) by forming a dispersion of titanium dioxide particles having a median particle volume diameter of less than 85nm in an organic dispersing medium, and incorporating the dispersion directly into an organic resin. A method of producing this UV absorbing polymeric composition is also disclosed, which comorises the steps of providing (i) a masterbatch composition having an extinction coefficient at 524nm (E524) of less than 2.0 l/g/cm, an extinction coefficient at 308 nm (E308) of greater than 20 l/g/cm and an E308/E524 ratio of greater than 10 comprises an organic resin, an organic dispersing medium and titanium dioxide particles is obtained by mixing a dispersion of titanium dioxide particles having a median particle volume diameter of less than 85nm in an organic dispersing medium, with an organic resin, and mixing the masterbatch composition with a substrate organic resin, or (ii) a dispersion of titanium dioxide particles in an organic dispersing medium, and incorporating the dispersion directly into a substrate organic resin.
Patent NZ-573908-A (NZ)
Title: Steering unit for free flying, confined wing element having an actuator varying the distance between a fixed attachment point and movable left and right attachment points.
Inventor: WRAGE STEPHAN
IPC: B63B35/79
Filed: 2006-09-14
Abstract: A steering unit for a wind propulsion system is disclosed. The steering unit has a first fixed attachment means for securing a first end of a tractive cable (43) the second end of the tractive cable is secured to a device or a vehicle. The steering unit also has second attachment means for attaching a number of tractive lines (40a, 40b, 41a, 41b). The second attachment means includes at least one upper fixed attachment point (for fixed tractive lines 41a, 41b), a left moveable attachment point (for steering tractive line 40a), a right moveable attachment point (for steering tractive line 40b) and a steering actuator means. The steering actuator means can vary the distance between the upper fixed attachment point and the left moveable attachment point and the distance between the upper fixed attachment point and the right moveable attachment point. A mechanical support frame (30) connects the first attachment means to the second attachment means for transferring a tractive force. The second ends of the tractive lines (40a, 40b, 41a, 41b) are secured to an aerodynamic wing element (10).
Patent NZ-577948-A (NZ)
Title: Drug delivery implants for inhibition of optical defects
Inventor: DE JUAN JR
IPC: A61M35/00
Filed: 2007-12-21
Abstract: Disclosed is a punctal plug comprising a structure insertable through a punctum of an eye and a therapeutic agent comprising a mydriatic drug, and deliverable from the structure into the eye to therapeutically effect and/or stabilize a refractive property of the eye; wherein the structure includes at least one surface configured to release a therapeutic quantity of the therapeutic agent into tear or tear film fluid of the eye when exposed thereto. Further disclosed is a punctal plug comprising a structure, a punctal insert to retain the structure adjacent to an eye and a therapeutic agent deliverable from the structure into the eye to therapeutically effect and/or stabilize one or more refractive properties of the eye, the therapeutic agent comprising a mydriatic drug.
Patent NZ-588605-A (NZ)
Title: Novel and powerful mhc-class ii petptides derived from survivin
Inventor: STEVANOVIC STEFAN
IPC: A61K38/00
Filed: 2009-05-14
Abstract: Disclosed are peptides, nucleic acids, and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to survivin-derived tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention specifically relates to three novel peptide sequences and variants thereof derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
Patent NZ-589238-A (NZ)
Title: Polypeptides from staphylococcus aureus and methods of use
Inventor: EMERY DARYLL A
IPC: A61K39/40
Filed: 2006-02-14
Abstract: Provided is the use of a composition in the preparation of a medicament for treating an infection in a subject caused by a Staphylococcus spp., or for treating a subject at risk of having an infection caused by a Staphylococcus spp., wherein the composition comprises: at least three isolated polypeptides having molecular weights of 88 kDa, 55 kDa, 38 kDa, 37 kDa, 36 kDa, 35 kDa, 33 kDa, or a combination thereof, wherein molecular weight is determined by electrophoresis on a sodium dodecyl sulphate polyacrylamide gel, wherein the polypeptides are isolatable from a Staphylococcus aureus when incubated in media comprising an iron chelator and not isolatable when grown in the media without the iron chelator, and wherein the composition protects an animal against challenge with S. aureus ATCC strain 19636.
Patent NZ-590897-A (NZ)
Title: ORAL FORMULATION COMPRISING (4-((1R,3S)-6-chloro-3-phenylindan-l-yl)-1,2,2-trimethylpiperazine)
Inventor: HOLM RENE
IPC: A61P25/24
Filed: 2009-10-01
Abstract: Disclosed herein is a pharmaceutical composition comprising 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine (compound of formula (I)), in a therapeutically effective amount of from 4-14mg calculated as the free base, wherein said compound in is the form of a succinate or malonate salt, and wherein said composition is for oral administration once daily.
Patent NZ-592348-A (NZ)
Title: Double opening system for beverage cans
Inventor: TAMARIT RIOS RAMON
IPC: B65D17/34
Filed: 2009-10-21
Abstract: 592348 The lid of a beverage can has two punched segments (2, 10), breaking of which forms the respective openings for allowing the liquid to flow out and the air to enter. Breaking of these punched parts is performed by pivoting upwards a main ring (1) mounted on a rivet (5) of the lid and, after breaking open the punched part, pushing downwards a secondary lever (6) with cutting pressure pieces which cut into the punched parts so as to cause breakage thereof. The secondary lever is mounted on the same rivet, having an end segment which rests against a stop of the ring in order to prevent in the rest condition the pressure pieces cutting into the punched parts. In another simpler embodiment, the secondary lever is dispensed with, so that the pressure piece is incorporated along the contour of the associated main ring.